ASTuTE clinical trial: Advancing cancer management with AI

Prostate cancer is the most commonly diagnosed male malignancy, with over 25,500 cases estimated in Australia in 2023. Although frequently slow-growing and often manageable with effective treatments, prostate cancer remains the leading cause of cancer-related disability worldwide.